引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 【查看/发表评论】【下载PDF阅读器】【关闭】

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 169次   下载 165次 本文二维码信息
码上扫一扫!
温肺益气方辅助治疗小儿肺气虚寒型变应性鼻炎的回顾性分析及对血清炎症因子、免疫功能的影响
赵荣,刘杨,黄涛
((恩施土家族苗族自治州中心医院,湖北恩施 445000))
摘要:
目的:评估温肺益气方治疗小儿肺气虚寒型变应性鼻炎(AR) 的临床疗效,并探讨其对血清炎症因子及免疫功能的影 响。方法:采用回顾性研究方法,选取我院2022 年7 月至2024 年7 月收治的肺气虚寒型AR 患儿82 例,按不同干预方法分为 对照组和观察组各41 例。对照组采用盐酸西替利嗪治疗,观察组加用温肺益气方煎汤口服,均治疗4 周。比较两组患儿治疗 前后临床疗效、中医证候积分、鼻气道阻力、血清免疫球蛋白(Ig)E、CD4+ 、CD8+ 、嗜酸性粒细胞(EOS)、白细胞介素(IL)-4、IL-5、 IL-17、鼻炎症状量表(TNSS)评分、生命质量问卷(RQLQ)评分等。结果:观察组治疗有效率高于对照组(P<0. 05)。治疗后,观 察组中医证候积分、鼻气道阻力、TNSS、RQLQ 评分低于对照组(均P<0. 05),炎症因子水平低于对照组(校正后均q<0. 05);免 疫功能指标优于对照组(校正后均q<0. 05)。结论:温肺益气方治疗小儿肺气虚寒型AR 患儿的临床疗效较好,有助于改善中 医证候积分、鼻气道阻力,调节炎症因子与免疫系统,缓解临床症状,提高短期生活质量,且安全性良好。
关键词:  变应性鼻炎  儿童  温肺益气方  肺气虚寒证  炎症  免疫功能
DOI:doi:10.13407/j.cnki.jpp.1672-108X.2026.10.012
基金项目:
Retrospective Analysis of Wenfei Yiqi Formula in the Adjuvant Treatment of Children with Allergic Rhinitisof Lung Qi Deficiency and Cold Type and Its Effects on Serum Inflammatory Factors and Immune Function
Zhao Rong, Liu Yang, Huang Tao
((Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Hubei Enshi 445000, China))
Abstract:
Objective: To evaluate the clinical efficacy of Wenfei Yiqi formula in the treatment of children with allergic rhinitis (AR) of lung Qi deficiency and cold type, and probe into its effects on serum inflammatory factors and immune function. Methods: Retrospective analysis was performed on 82 children with AR of lung Qi deficiency and cold type admitted into our hospital from Jul. 2022 to Jul. 2024. All patients were divided into the control group and observation group according to different interventions, with 41 cases in each group. The control group received cetirizine hydrochloride alone, while the observation group was given additional oral administration of Wenfei Yiqi decoction, both groups were treated for 4 weeks. The clinical efficacy, traditional Chinese medicine (TCM) syndrome scores, nasal airway resistance, serum immunoglobulin E (IgE), CD4+ , CD8+ , eosinophil (EOS) counts, interleukin (IL)-4, IL-5, IL-17 levels, Total Nasal Symptom Score (TNSS), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores were compared between two groups before and after treatment. Results: The overall response rate in observation group was significantly higher than that in control group. After treatment, the traditional Chinese medicine syndrome scores, nasal airway resistance, TNSS, RQLQ scores in observation group were lower than those in control group (P<0. 05), inflammatory cytokine levels were lower than those in control group (adjusted q<0. 05), and immune function parameters were better than those in control group (adjusted q<0. 05). Conclusion: Wenfei Yiqi formula demonstrates favorable clinical efficacy in children with AR of lung Qi deficiency and cold type, as evidenced by improvements in traditional Chinese medicine syndrome scores, nasal airway resistance, modulation of inflammatory cytokines and immune function, alleviation of clinical symptoms, enhancement of short-term quality of life with higher safety.
Key words:  allergic rhinitis  children  Wenfei Yiqi formula  lung Qi deficiency and cold type  inflammation  immune function

用微信扫一扫

用微信扫一扫